Aurobindo Pharma gets USFDA nod for Tofacitinib tablets

Aurobindo Pharma gets USFDA nod for Tofacitinib tablets — Aurobindo Pharma has received USFDA approval for Tofacitinib tablets, a generic version of Xeljanz. The drug is used to treat rheumatoid arthritis and other inflammatory conditions. This approval expands Aurobindo’s presence in the US generics market. Launch timing and market share impact remain to be seen.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA